Our "insight" early data release at ASCO will be of interest to many....Avelumab has a rap sheet
as long as your arm in regard to side effects but it has approval due to scarcity of other treatments
available...Very small trial and wont effect the market in my mind but we will see....
Our "insight" early data release at ASCO will be of interest to...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.025(8.06%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.8¢ | 31.3¢ | $1.379M | 4.179M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 170360 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 115131 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |